ADMA - Financial Reports List - ADMA Biologics, Inc. - IntrinsicAlpha

ADMA Biologics, Inc. ADMA

Healthcare - Biotechnology - NASDAQ - US

$ 16.5

0.671 %

$ 3.9 B

Market Cap

61.11

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q3	8-K	2024-09-30	78.13%	1299.93%	356.39%
Quarterly Report	Q2	8-K	2024-06-30	78.29%	603.27%	8386.39%
Quarterly Report	Q1	8-K	2024-03-31	43.86%	239.50%	2782.96%
Quarterly Report	Q4	8-K	2023-12-31	47.86%	-44.25%	334.93%
Annual Report	FY	10-K	2023-12-31	67.59%	66.85%	154.95%
Quarterly Report	Q3	8-K	2023-09-30	63.72%	112.52%	193.22%
Quarterly Report	Q2	8-K	2023-06-30	77.33%	53.72%	94.84%
Quarterly Report	Q1	8-K	2023-03-31	95.56%	63.74%	94.51%
Quarterly Report	Q4	8-K	2022-12-31	89.45%	26.53%	54.07%
Annual Report	FY	10-K	2022-12-31	90.36%	-0.86%	32.56%

1